According to the CDC, people on medication who are virally suppressed and have adequate immune responses are not at a higher risk of severe illness and death from COVID-19. However, factors common in some people living with HIV, in particular co-morbidities, do greatly increase the risk of poorer outcomes.
Despite COVID-19 creating unparalleled changes in how we live, theres been little discussion on how the Ryan White CARE Act, PEPFAR, and the Global Fund for AIDS, TB and Malaria will address safe practices, particularly at AIDS service organizations, and how these measures will be evaluated and where the funding for these provisions will come from. As restrictions continue to be lifted, how will people living with HIV at higher risk of illness safely receive services and medical care until there is a preventative vaccine?
Estimations suggest that it will be the spring of 2021 before a vaccine could be available to the general public. Although vaccine studies are moving forward at an unprecedented rate, clinical trials take time and it may take numerous attempts to discover a vaccine candidate that is safe and effective. After an effective vaccine is found, it will then take additional time to produce and distribute the vaccine globally. In the meantime, a significant risk will exist for some people living with HIV in accessing essential services.
Of the 1.1 million people in the U.S. currently living with HIV, only 53 percent are virally suppressed. In 2018, 17,032 individuals in the U.S. received an AIDS diagnosis. Initial observations indicate those with CD4 counts below 50 are at a higher risk for severe COVID-19. Viral suppression is most often needed to prevent further deterioration of the immune system and for the immune system to once again become effective at fighting off pathogens such as viruses and bacteria. However, not all virally suppressed individuals see a complete rebound of their immune system. Some people, particularly those who began antiretroviral therapy (ARVs) when their CD4 count was below 200, experience a decreased improvement in CD4s which may not return to normal levels.
Many people living with HIV experience co-morbidities which also significantly increase their risk of severe illness with COVID-19. Heart disease, diabetes, liver and kidney disease, and certain cancers are commonly seen in people living with HIV, particularly as they age. A recent South African study found the death rate of people co-infected with HIV and COVID-19 was 2.75-fold higher than those without HIV of equal age. Investigators determined that most of the individuals in this study had additional conditions including diabetes, and viral suppression or non-suppression was not a determining factor. In total, there is a large number of people living with HIV for who safeguards should be put in place to reduce the likelihood of COVID-19 infection where possible.
Many people living with HIV receive vital services such as case management, food pantry, benefits counseling, housing assistance, treatment, and substance abuse referrals from AIDS service organizations and community-based organizations. Currently many organizations are temporarily closed or conducting onsite screening for symptoms of COVID-19 as well as offering teleconference services to their clients for certain programs. However, some services can only be accessed in person. As states reopen, AIDS service organizations, harm reduction centers, mental health and substance abuse facilities will need to make long-term adjustments in the way they provide basic services in order to protect their clients and staff.
Social distancing and symptom screening have become normalized practices with the restructuring of offices, waiting rooms, conference rooms, and other closed environments that people frequent simultaneously. Teleconferencing and phone appointments are now common in clinical practice. Hours are also extended or decreased to limit the number of individuals who occupy a given space at the same time. Another vital preventative method against COVID infection is environmental sterilization (remediation).
How will AIDS service organizations, already running on shoestring budgets, absorb the cost of the remediation needed to prevent COVID-19 and why are these sterilization procedures not being discussed as an overall strategy? Studies show that COVID-19 can remain infectious on different surfaces in different environmental conditions. The New England Journal of Medicine reported that studies showed the virus was detectable on copper for up to four hours, on cardboard for up to 24 hours, and on plastic and steel for up to 72 hours. Over these periods, the viruss genetic code begins to deteriorate, but were unsure how quickly this occurs and at what point it becomes non-infectious.
Well thought-out plans for protecting vulnerable populations need to be proposed and carried out through state and federal recommendations and mandates, stated Dr. Roscoe Moore, former Assistant Surgeon General and Board Member of the Global Virus Network of The Institute of Human Virology.
Federal, state, and municipal governments are implementing strategies, albeit slower than expected, to protect the elderly, immune-compromised, and people with underlining conditions such as those we see in a growing percentage of people living with HIV and AIDS from COVID-19 acquisition. Proven social distancing measures in combination with additional support for those at risk and effective remediation of support service centers including AIDS service organizations, will help keep new infections down and protect those at highest risk.
Regular cleaning of places people living with HIV frequent will no longer be sufficient in protecting those most vulnerable to COVID-19. These service providers will need to adapt new procedures that, through remediation procedures, will lessen the possibility of people becoming infected. Employing effective remediation of surfaces exposed to COVID-19 should be a priority along with other prevention methods.
One currently available method uses hypochlorous acid, which has been proven to be effective when dispersed in a electrostatic spray that completely covers any area being remediated for COVID-19. A second application of an antimicrobial being studied by independent labs, known commercially as SHIELD, is then disbursed, providing a molecular barrier to all surfaces from new containments for 90 days. The ionized microbicide clings to surfaces, which destroy viruses on contact. This method, performed by Germinator Mobile Sanitizing and Disinfection, should be evaluated for use at AIDS service organizations and other public spaces frequented by at higher risk individuals.
Another method was shown in recent studies by TheGlobal Virus Network, a coalition comprised of the worlds preeminent human and animal virologists in 32 countries. GVN announced in early June that two of its partners, the Peter Doherty Institute for Infection and Immunity in Australia, and the Rega Medical Research Institute of KU Leuven in Belgium, demonstrated that a quaternary ammonium sulfide biocide compound called BIOPROTECT inactivates SARS-CoV-2 (the coronavirus that causes COVID-19) on surfaces, providing continuous residual viricidal activity for at least 46 days. The tests conducted were designed to conform with the U.S. Environmental Protection Agency and equivalent standards of regulatory agencies in Europe and Australia.
The results of the tests conducted by the Doherty and the Rega Institutes demonstrate that BIOPROTECT eradicates SARS-CoV-2 on surfaces and provides continuous residual antimicrobial protection for an extended period of time, said Dr. Christain Brchot, president of GVN. Effective antimicrobials will be extremely important in containing the COVID-19 pandemic, given the time it will take to implement mass vaccination and fully develop novel therapies.This represents a significant breakthrough in inhibiting the spread of COVID-19 by preventing surfaces from being contaminated by the virus.
Remediation is in its initial stages of development for reducing new COVID-19 infections. Yet, theres still no guidance on evaluating and employing remediation methods at AIDS service organizations by HIV planning councils around the country or by leading AIDS advocacy organizations like the International AIDS Society, AIDS United, or the National Minority AIDS Council, and no current funding mechanism exists for remediating the predictable risk of COVID-19 exposure at these places through Ryan White CARE Act funding. Evaluating this important method of protecting those at greater risk should be a priority.
As we prepare for COVID- 19 sticking around for a while, its critical to ensure people living with HIV are not lost to another epidemic.
Jeannie Wraight is a health writer and frequent contributor to Plus. Follow her on Twitter @JeaWra.
See the original post:
People Living With HIV Need a Safe Way to Access Services During COVID - HivPlusMag.com
- Utilizing your free, preventative healthcare coverage - KELOLAND.com - February 18th, 2024
- Preventive Pros: the Podcast - Department of Population and Public Health Sciences - University of Southern California - February 18th, 2024
- Heart health awareness and preventative care with Jen Lewis on Coast Live - News 3 WTKR Norfolk - February 18th, 2024
- Heart disease risk factors in women highlight need for increased awareness, prevention - American Heart Association - February 18th, 2024
- Preventive health care benefits | Opinion | thecabin.net - Log Cabin Democrat - February 18th, 2024
- Menopause and migraines: New findings point to power of prevention - Medical Xpress - February 18th, 2024
- How Young Is Too Young For Preventative Skincare? Here's What Experts Want You To Know - Health.com - February 18th, 2024
- Potential prevention of rheumatoid arthritis with injection? Clinical study brings hope for millions - WION - February 18th, 2024
- Heart disease risk factors in women highlight need for increased awareness, prevention - Medical Xpress - February 18th, 2024
- Stay on top of your fur baby's health: the importance of scheduling routine vet visits - FoxReno.com - May 17th, 2023
- Preventive healthcare - May 9th, 2023
- What Is Preventive Health and Why Is It Important? - May 9th, 2023
- What Is Preventive Medicine & Why Do We Need It? | AUC - February 16th, 2023
- Preventive Medicine | Journal | ScienceDirect.com by Elsevier - December 3rd, 2022
- Migraine - Diagnosis and treatment - Mayo Clinic - December 3rd, 2022
- Functional Medicine of Idaho | Preventative Root Cause Medicine - December 3rd, 2022
- These 2 Staten Island nurses believe IV hydration drips and vitamin shots are key to long-term health - SILive.com - December 3rd, 2022
- CNBCTV-18 and IIM-K's India@2047 Leadership Series: Challenges and opportunities in the fintech and healthcare sectors - Forbes India - December 3rd, 2022
- As N.W.T. mulls health coverage changes, petition calls for preventative HIV drug to be free - CBC.ca - September 20th, 2022
- EU regulator backs wider use of AstraZeneca COVID therapy - Reuters - September 20th, 2022
- Choose integrative medicine for health and wellness - Technique - September 20th, 2022
- The high hospital bills we make victims of rape and sexual violence pay - Vox.com - September 20th, 2022
- 4 Anti-Aging Products Youre Using All Wrong, According To Skincare Experts - SheFinds - September 20th, 2022
- Why Now is the Time to Double Down on Virtual Care - HIT Consultant - September 20th, 2022
- Tell Giselle: The price of good help is priceless - Wilkes Barre Times-Leader - September 20th, 2022
- Heron Therapeutics Announces U.S. FDA Approval of APONVIE (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV) - BioSpace - September 20th, 2022
- Pickleball injuries are on the rise: 5 preventive tips to keep you on the court - The Manual - September 20th, 2022
- The next big social movement and other takeaways from our regular meeting - POLITICO - September 20th, 2022
- 15 Mushrooms and How to Use Them in Vegan Cooking - VegNews - September 20th, 2022
- Use of honey in the management of Chemotherapy | CMAR - Dove Medical Press - September 20th, 2022
- Celebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry - Forbes - September 20th, 2022
- C2C Care Course The Preservation of Our Global Photographic Heritage: Here, There and Everywhere - aam-us.org - August 3rd, 2022
- Loneliness: Causes, Effects And Prevention Forbes Health - Forbes - August 3rd, 2022
- Prevention and wellness is the new model, a leader from Henry Ford Health System says - Becker's Hospital Review - August 3rd, 2022
- FACT SHEET: White House Summit on Building Lasting Eviction Prevention Reform - The White House - August 3rd, 2022
- Getting Back to Employer Health and Wellness Programs - Cone Health - August 3rd, 2022
- Do ICDs Still Work in Primary Prevention Given Today's HF Meds? - Medscape - August 3rd, 2022
- Alzheimer's-defying brain offers clues to treatment, prevention - Harvard Gazette - August 3rd, 2022
- Wind-fanned lightning fire prompted precautionary evacuation notices near Medical Springs Sunday evening - Baker City Herald - August 3rd, 2022
- Experts discuss importance of cancer screenings and early detection - Merck - August 3rd, 2022
- King Institute of Preventive Medicine and Research to test samples for monkeypox - The Hindu - August 3rd, 2022
- Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations - World - ReliefWeb - August 3rd, 2022
- Dr. Sanjay Gupta: While monkeypox cases rise, why are we waiting for the cavalry to rescue us? - CNN - August 3rd, 2022
- SCYNEXIS Announces U.S. Food and Drug Administration - GlobeNewswire - August 3rd, 2022
- Governor Whitmer declares August 2022 as Breastfeeding Month, highlights additional breastfeeding observances - Michigan (.gov) - August 3rd, 2022
- New student education program supports drug and alcohol abuse prevention - The Ohio State University News - July 25th, 2022
- Suicide prevention training for health care providers a first step in longer-term efficacy - University of Washington - July 25th, 2022
- Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug - STAT - July 25th, 2022
- Prevention of Bipolar Disorder Episodes: Is It Possible? - PsychCentral.com - July 25th, 2022
- GAO Found Gap in Dirty Bomb Prevention - Government Technology - July 25th, 2022
- Florida man in apparent medical distress crashes car through beach crowd before hitting the water - CNN - July 25th, 2022
- Study: Preventive care scarce in LGBTQ+ community - - Medical Marketing and Media - July 25th, 2022
- The rise of preventive insurance purchases in India - ETHealthWorld - July 25th, 2022
- Why Are My Feet Always Cold? Cold Feet Causes and Treatment - Prevention Magazine - July 25th, 2022
- Agency looking to open overdose prevention site in Saint John amid 'poisoned' drug supply - CBC.ca - July 25th, 2022
- UVA Expert Offers Insight on the Use of Dietary Supplements for Cancer Prevention - UVA Today - July 25th, 2022
- Alzheimer's: Targeting key protein in blood may slow progression - Medical News Today - July 25th, 2022
- NPPC, FAS focused on ASF prevention in the Philippines - MEAT+POULTRY - July 25th, 2022
- Implementation of IPT in people living with HIV | RMHP - Dove Medical Press - July 25th, 2022
- NL starts preventive vaccination against monkeypox in Amsterdam, The Hague - NL Times - July 25th, 2022
- Precautionary measures you can take against brain haemorrhage - Times of India - July 25th, 2022
- Acid Reflux and Liver Disease: Signs, Symptoms and Prevention - Healthline - July 25th, 2022
- What to do if you get an allergic reaction: symptoms, causes, and prevention - Fox News - July 25th, 2022
- How one woman took control of her rare disease and achieved her dream - Times of Oman - July 25th, 2022
- Tilman Fertitta donating $50 million to UH medical school, which will be renamed after him - Houston Chronicle - May 20th, 2022
- This new 3D screensaver collection includes a driving tour of global pylons - Rock Paper Shotgun - May 20th, 2022
- Dedication, generosity and compassion that had no limit! - The Sun Chronicle - May 20th, 2022
- Manhattan internist and cardiologist, Dr. William Priester collaborates with Castle Connolly Private Health Partners to create a new concierge medical... - May 20th, 2022
- Tips on avoiding mosquitos this summer - morethanthecurve.com - May 20th, 2022
- Nanomedicine and HIV Therapeutics - AZoNano - May 20th, 2022
- The HIV Vaccine: What We Know, And What We Don't - MadameNoire - May 20th, 2022
- What we know (and don't know) about North Korea's COVID-19 outbreak - WCVB Boston - May 20th, 2022
- Experts warn of health effects from dusty conditions as sandstorm blankets UAE - Al Arabiya English - May 20th, 2022
- Statin therapy: Does the gut microbiome affect outcomes? - Medical News Today - May 20th, 2022
- New Preventative Medicine Facility Wraps Work in NYC - Healthcare Construction and Operations News - November 7th, 2021
- MPD working with faith-based leaders to fight violent crime - FOX13 Memphis - November 7th, 2021
- Cornell grad and lecturer touts benefits of plant-based diet - ithaca.com - November 7th, 2021
- Meet the Cork-born bread activist who has Goldie Hawn buying her loaves - Irish Examiner - November 7th, 2021
- Pfizer says pill cuts risk of severe Covid by 89% - RTE.ie - November 7th, 2021
- The roots of ivermectin mania: How South America incubated a fake-medicine craze that took the US by storm - Yahoo News - November 7th, 2021